Among these PRRs, Toll-Like receptors (TLRs) have been the most studied, with 6 gathering a significant interest in cancer vaccines, namely TLR-2, -3, -4, -7/-8, and -9 (Gay and Gangloff, 2007). Here, TLR2 is linked to cancer.